SHANNON KHULUSI: Open Payments
NPI 1932240603 · EATONTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,617 in 155 payments from 22 companies in 2025. Trend: 2023 $1,970 · 2024 $2,300 · 2025 $2,617
Food & beverage: $2,607Education: $10
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 22 | $487 |
| ABBVIE INC. | 30 | $403 |
| Janssen Biotech, Inc. | 19 | $288 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $244 |
| Lilly USA, LLC | 12 | $218 |
| GENZYME CORPORATION | 10 | $194 |
| PFIZER INC. | 10 | $167 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $91 |
| Regeneron Healthcare Solutions, Inc. | 4 | $78 |
| QOL Medical, LLC | 4 | $76 |
Products named: REZDIFFRA, TREMFYA, DUPIXENT, OMVOH, ENTYVIO, RINVOQ, VELSIPITY, Sucraid.
Industry payments across NJ — which companies pay providers there.
